1. Home
  2. LEGN vs REXR Comparison

LEGN vs REXR Comparison

Compare LEGN & REXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • REXR
  • Stock Information
  • Founded
  • LEGN 2014
  • REXR 2013
  • Country
  • LEGN United States
  • REXR United States
  • Employees
  • LEGN N/A
  • REXR N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • REXR Real Estate Investment Trusts
  • Sector
  • LEGN Health Care
  • REXR Real Estate
  • Exchange
  • LEGN Nasdaq
  • REXR Nasdaq
  • Market Cap
  • LEGN 7.0B
  • REXR 7.7B
  • IPO Year
  • LEGN 2020
  • REXR 2013
  • Fundamental
  • Price
  • LEGN $28.33
  • REXR $34.02
  • Analyst Decision
  • LEGN Strong Buy
  • REXR Hold
  • Analyst Count
  • LEGN 13
  • REXR 9
  • Target Price
  • LEGN $75.67
  • REXR $39.67
  • AVG Volume (30 Days)
  • LEGN 1.6M
  • REXR 2.1M
  • Earning Date
  • LEGN 05-13-2025
  • REXR 07-16-2025
  • Dividend Yield
  • LEGN N/A
  • REXR 5.06%
  • EPS Growth
  • LEGN N/A
  • REXR 12.67
  • EPS
  • LEGN N/A
  • REXR 1.23
  • Revenue
  • LEGN $728,303,000.00
  • REXR $974,598,000.00
  • Revenue This Year
  • LEGN $64.21
  • REXR $9.78
  • Revenue Next Year
  • LEGN $53.69
  • REXR $8.46
  • P/E Ratio
  • LEGN N/A
  • REXR $27.68
  • Revenue Growth
  • LEGN 112.46
  • REXR 18.04
  • 52 Week Low
  • LEGN $27.34
  • REXR $29.68
  • 52 Week High
  • LEGN $60.87
  • REXR $52.61
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 36.81
  • REXR 44.81
  • Support Level
  • LEGN $27.34
  • REXR $34.78
  • Resistance Level
  • LEGN $33.30
  • REXR $35.77
  • Average True Range (ATR)
  • LEGN 1.91
  • REXR 0.72
  • MACD
  • LEGN -0.30
  • REXR 0.19
  • Stochastic Oscillator
  • LEGN 13.51
  • REXR 21.91

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About REXR Rexford Industrial Realty Inc.

Rexford Industrial Realty Inc is a real estate investment trust engaged in owning, operating, and acquiring industrial properties in Southern California infill markets. The goal is to generate attractive risk-adjusted returns for stockholders by providing superior access to industrial property investments in Southern California infill markets. It has one operating segment business of investing in, operating, and repositioning/redeveloping industrial real estate properties located in Southern California infill markets.

Share on Social Networks: